Related Experiment Video
Updated: Oct 1, 2026
Assessment of the Immunomodulatory Properties of Human Mesenchymal Stem Cells (MSCs)
Published on: December 24, 2015
In vivo and in vitro effects of methylprednisolone on human lymphocyte proliferation
Abstract:
Lymphocytes obtained from normal volunteers 4 hr after intravenous methylprednisolone (1 mg/kg of body weight) were significantly less stimulated in vitro by several concentrations of phytohemagglutinin and concanavalin A. This effect was not due to diurnal variations. Significant decreases in the levels of circulating T lymphocytes (p < 0.001) at this time suggested cellular redistribution as a factor in decreased mitogen responsiveness. However, incubation of plasma, obtained 1 hr after methylprednisolone injection, with normal autologous lymphocytes suppressed the in vitro responses as well, indicating an additional direct corticosteroid effect on the lymphocytes.
Insights
Methylprednisolone treatment reduces lymphocyte response to mitogens like phytohemagglutinin. This occurs due to both T lymphocyte redistribution and a direct corticosteroid effect on lymphocytes.
Area of Science:
- Immunology
- Pharmacology
- Endocrinology
Background:
- Glucocorticoids, such as methylprednisolone, are potent immunomodulatory agents.
- Understanding the precise mechanisms of corticosteroid-induced immunosuppression is crucial for clinical applications.
Purpose of the Study:
- To investigate the impact of methylprednisolone on lymphocyte responsiveness to common mitogens.
- To differentiate between cellular redistribution and direct drug effects on lymphocytes.
Main Methods:
- Lymphocytes from healthy volunteers were isolated 4 hours after intravenous methylprednisolone administration (1 mg/kg).
- In vitro stimulation assays were performed using phytohemagglutinin and concanavalin A.
- Plasma from methylprednisolone-treated individuals was incubated with autologous lymphocytes to assess direct effects.
Main Results:
- Lymphocyte stimulation by phytohemagglutinin and concanavalin A was significantly reduced post-methylprednisolone treatment.
- A decrease in circulating T lymphocytes was observed, suggesting cellular redistribution.
- Plasma from treated subjects directly suppressed lymphocyte responses, indicating an additional corticosteroid effect.
Conclusions:
- Methylprednisolone impairs lymphocyte mitogenic responsiveness through a dual mechanism.
- Both the redistribution of T lymphocytes and a direct corticosteroid action contribute to immunosuppression.
